Beta-2-Microglobulin (lymphomas)

At IntroLab laboratory, our experts perform Beta-2-Microglobulin analysis with high precision and speed. The results of this analysis provide useful information for the diagnosis, monitoring, and therapeutic management of lymphomas, enabling patients and doctors to make informed decisions about the further course of treatment.

What is Beta-2-Microglobulin (lymphomas)?

Beta-2-Microglobulin is a small protein substance naturally secreted in the body. It plays an important role in the immune system and helps maintain the normal function of the immune response. However, in certain malignant diseases such as lymphomas, the level of Beta-2-Microglobulin can be elevated, indicating the presence of the disease and its progression.

Lymphomas are a group of malignant tumors that develop in the lymphatic system, which is part of the body’s immune system. The lymphatic system includes lymph nodes, spleen, tonsils, thymus, and bone marrow. When lymphoma occurs, malignant cells multiply in lymph nodes and other parts of the lymphatic system.

When is Beta-2-Microglobulin analysis (lymphomas) performed?

Beta-2-Microglobulin analysis (lymphomas) is usually recommended when there is a suspicion of the presence or monitoring of lymphoma. Here are some situations and symptoms that may indicate the need for this analysis:

• When lymphoma or multiple myeloma is suspected or diagnosed.
• When assessing the effectiveness of therapy for lymphoma or multiple myeloma.

High levels of Beta-2-Microglobulin

Elevated levels of Beta-2-Microglobulin often indicate increased lymphoma activity. This can mean that the disease is spreading or progressing. High levels of Beta-2-Microglobulin can be useful for diagnosing lymphoma and monitoring during therapy. They may also indicate a poorer prognosis or the need for a more intensive therapeutic approach.

Low levels of Beta-2-Microglobulin

Low levels of Beta-2-Microglobulin are usually considered a favorable sign. They can indicate lower lymphoma activity or a good therapeutic response. Low levels of Beta-2-Microglobulin can be associated with a better prognosis and a positive outcome for patients with lymphoma.